12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga·03/03/2026 21:05:58
Listen to the news
Gainers
AN2 Therapeutics (NASDAQ:ANTX) shares increased by 16.0% to $1.23 during Tuesday's after-market session. The market value of their outstanding shares is at $29.5 million.
Mira Pharmaceuticals (NASDAQ:MIRA) shares increased by 8.06% to $1.34. The company's market cap stands at $54.0 million.
20/20 Biolabs (NASDAQ:AIDX) stock increased by 7.45% to $3.17. The market value of their outstanding shares is at $35.0 million.
Healthcare Triangle (NASDAQ:HCTI) stock increased by 5.59% to $3.06. The company's market cap stands at $2.6 million.
Reviva Pharmaceuticals (NASDAQ:RVPH) stock moved upwards by 4.5% to $0.23. The company's market cap stands at $26.8 million.
Propanc Biopharma (NASDAQ:PPCB) stock rose 4.22% to $0.18. The market value of their outstanding shares is at $2.8 million.
Losers
Edesa Biotech (NASDAQ:EDSA) shares fell 6.9% to $4.05 during Tuesday's after-market session. The market value of their outstanding shares is at $19.0 million.
HCW Biologics (NASDAQ:HCWB) shares declined by 6.07% to $0.62. The company's market cap stands at $1.8 million.
Theriva Biologics (AMEX:TOVX) shares fell 3.33% to $0.18. The company's market cap stands at $7.0 million.
Cardio Diagnostics Hldgs (NASDAQ:CDIO) shares declined by 3.17% to $4.59. The market value of their outstanding shares is at $9.4 million.
Aprea Therapeutics (NASDAQ:APRE) shares decreased by 3.01% to $0.82. The company's market cap stands at $6.1 million.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.